{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:12:28Z","timestamp":1790187148227,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ: 01ZX1311A"],"award-info":[{"award-number":["FKZ: 01ZX1311A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAPES Foundation, Ministry of Education of Brazil","award":["DF 70040-020"],"award-info":[{"award-number":["DF 70040-020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00213-018-4893-9","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T15:07:54Z","timestamp":1523545674000},"page":"1955-1965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction"],"prefix":"10.1007","volume":"235","author":[{"given":"Valentina","family":"Vengeliene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane T.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Dravolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Belozertseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Zvartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton Y.","family":"Bespalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spanagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"4893_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnins.2014.00140","volume":"8","author":"R Agabio","year":"2014","unstructured":"Agabio R, Colombo G (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8:140","journal-title":"Front Neurosci"},{"key":"4893_CR2","unstructured":"ANSM (2017) Le Baclof\u00e8ne en vie r\u00e9elle en France entre 2009 et 2015. Usages, persistance et s\u00e9curit\u00e9, et comparaison aux traitements des probl\u00e8mes d\u2019alcool ayant une autorisation de mise sur le march\u00e9. Rapport \u2013 25th of July, 2017 - www.ansm.sante.fr"},{"key":"4893_CR3","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","volume":"26","author":"EM Beraha","year":"2016","unstructured":"Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW (2016) Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial. Eur Neuropsychopharmacol 26:1950\u20131959","journal-title":"Eur Neuropsychopharmacol"},{"key":"4893_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00213-003-1769-3","volume":"174","author":"J Besheer","year":"2004","unstructured":"Besheer J, Lepoutre V, Hodge CW (2004) GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL\/6J mice. Psychopharmacology 174:358\u2013366","journal-title":"Psychopharmacology"},{"key":"4893_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pbb.2013.03.001","volume":"106","author":"TJ Beveridge","year":"2013","unstructured":"Beveridge TJ, Smith HR, Porrino LJ (2013) Differential development of tolerance to the functional and behavioral effects of repeated baclofen treatment in rats. Pharmacol Biochem Behav 106:27\u201332","journal-title":"Pharmacol Biochem Behav"},{"key":"4893_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2017.05.003","volume":"27","author":"A Braillon","year":"2017","unstructured":"Braillon A, Naudet F (2017) Baclofen and alcohol use disorders: from miracle to mirage. Eur Neuropsychopharmacol 27:691\u2013692","journal-title":"Eur Neuropsychopharmacol"},{"key":"4893_CR7","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0028-3908(99)00094-5","volume":"38","author":"K Brebner","year":"1999","unstructured":"Brebner K, Froestl W, Andrews M, Phelan R, Roberts DC (1999) The GABA(B) agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology 38:1797\u20131804","journal-title":"Neuropharmacology"},{"key":"4893_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00213-004-1968-6","volume":"177","author":"K Brebner","year":"2005","unstructured":"Brebner K, Ahn S, Phillips AG (2005) Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology 177:409\u2013417","journal-title":"Psychopharmacology"},{"key":"4893_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neuropharm.2015.10.009","volume":"101","author":"JW Brown","year":"2016","unstructured":"Brown JW, Moeller A, Schmidt M, Turner SC, Nimmrich V, Ma J, Rueter LE, van der Kam E, Zhang M (2016) Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA\/2J audiogenic seizure test: comparison to baclofen and utility as a pharmacodynamic screening model. Neuropharmacology 101:358\u2013369","journal-title":"Neuropharmacology"},{"key":"4893_CR10","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/npp.2013.106","volume":"38","author":"N Cannella","year":"2013","unstructured":"Cannella N, Halbout B, Uhrig S, Evrard L, Corsi M, Corti C, Deroche-Gamonet V, Hansson AC, Spanagel R (2013) The mGluR2\/3 agonist LY379268 induced anti-reinstatement effects in rats exhibiting addiction-like behavior. Neuropsychopharmacology 38:2048\u20132056","journal-title":"Neuropsychopharmacology"},{"key":"4893_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/adb.12500","volume":"23","author":"N Cannella","year":"2018","unstructured":"Cannella N, Cosa-Linan A, B\u00fcchler E, Falfan-Melgoza C, Weber-Fahr W, Spanagel R (2018) In vivo structural imaging in rats reveals neuroanatomical correlates of behavioral sub-dimensions of cocaine addiction. Addict Biol 23:182\u2013195","journal-title":"Addict Biol"},{"key":"4893_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/alcalc\/37.5.499","volume":"37","author":"G Colombo","year":"2002","unstructured":"Colombo G, Serra S, Brunetti G, Atzori G, Pani M, Vacca G, Addolorato G, Froestl W, Carai MA, Gessa GL (2002) The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol 37:499\u2013503","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"4893_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0376-8716(02)00333-2","volume":"70","author":"G Colombo","year":"2003","unstructured":"Colombo G, Serra S, Brunetti G, Vacca G, Carai MA, Gessa GL (2003) Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 70(1):105\u2013108","journal-title":"Drug Alcohol Depend"},{"key":"4893_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejphar.2006.08.052","volume":"550","author":"G Colombo","year":"2006","unstructured":"Colombo G, Serra S, Vacca G, Carai MA, Gessa GL (2006) Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. Eur J Pharmacol 550:123\u2013126","journal-title":"Eur J Pharmacol"},{"key":"4893_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.1099020","volume":"305","author":"V Deroche-Gamonet","year":"2004","unstructured":"Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014\u20131017","journal-title":"Science"},{"key":"4893_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.npp.1300088","volume":"28","author":"P Ciano Di","year":"2003","unstructured":"Di Ciano P, Everitt BJ (2003) The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28:510\u2013518","journal-title":"Neuropsychopharmacology"},{"key":"4893_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejphar.2007.05.069","volume":"571","author":"M Filip","year":"2007","unstructured":"Filip M, Frankowska M (2007) Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur J Pharmacol 571:166\u2013173","journal-title":"Eur J Pharmacol"},{"key":"4893_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2014.06.016","volume":"88","author":"M Filip","year":"2015","unstructured":"Filip M, Frankowska M, Sadakierska-Chudy A, Suder A, Szumiec L, Mierzejewski P, Bienkowski P, Przegali\u0144ski E, Cryan JF (2015) GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Neuropharmacology 88:36\u201347","journal-title":"Neuropharmacology"},{"key":"4893_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2016.03.008","volume":"777","author":"C Froger-Coll\u00e9aux","year":"2016","unstructured":"Froger-Coll\u00e9aux C, Castagn\u00e9 V (2016) Effects of baclofen and raclopride on reinstatement of cocaine self-administration in the rat. Eur J Pharmacol 777:147\u2013155","journal-title":"Eur J Pharmacol"},{"key":"4893_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.neuropharm.2008.08.008","volume":"55","author":"T Gjoni","year":"2008","unstructured":"Gjoni T, Urwyler S (2008) Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA B receptor desensitization. Neuropharmacology 55:1293\u20131299","journal-title":"Neuropharmacology"},{"key":"4893_CR21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1187801","volume":"328","author":"F Kasanetz","year":"2010","unstructured":"Kasanetz F, Deroche-Gamonet V, Berson N, Balado E, Lafourcade M, Manzoni O, Piazza PV (2010) Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science 328:1709\u20131712","journal-title":"Science"},{"key":"4893_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/bcpt.12344","volume":"116","author":"LB Kiel","year":"2015","unstructured":"Kiel LB, Hoegberg LC, Jansen T, Petersen JA, Dalhoff KP (2015) A nationwide register-based survey of baclofen toxicity. Basic Clin Pharmacol Toxicol 116:452\u2013456","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4893_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/A:1022353923578","volume":"28","author":"A Lehmann","year":"2003","unstructured":"Lehmann A, Mattsson JP, Edlund A, Johansson T, Ekstrand AJ (2003) Effects of repeated administration of baclofen to rats on GABA B receptor binding sites and subunit expression in the brain. Neurochem Res 28:387\u2013393","journal-title":"Neurochem Res"},{"key":"4893_CR24","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/j.1530-0277.2012.01782.x","volume":"36","author":"P Maccioni","year":"2012","unstructured":"Maccioni P, Zaru A, Loi B, Lobina C, Carai MA, Gessa GL, Capra A, Mugnaini C, Pasquini S, Corelli F, Hyyti\u00e4 P, Lumeng L, Colombo G (2012) Comparison of the effect of the GABA\u0392 receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats. Alcohol Clin Exp Res 36:1748\u20131766","journal-title":"Alcohol Clin Exp Res"},{"key":"4893_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0014-2999(00)00772-X","volume":"408","author":"P Munzar","year":"2000","unstructured":"Munzar P, Kutkat SW, Miller CR, Goldberg SR (2000) Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats. Eur J Pharmacol 408:169\u2013174","journal-title":"Eur J Pharmacol"},{"key":"4893_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00213-003-1637-1","volume":"172","author":"NE Paterson","year":"2004","unstructured":"Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172:179\u2013186","journal-title":"Psychopharmacology"},{"key":"4893_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/15563650.2017.1284330","volume":"55","author":"F Pelissier","year":"2017","unstructured":"Pelissier F, de Haro L, Cardona F, Picot C, Puskarczyk E, Sapori JM, Tournoud C, Franchitto N (2017) Self-poisoning with baclofen in alcohol-dependent patients: national reports to French poison control centers, 2008-2013. Clin Toxicol 55:275\u2013284","journal-title":"Clin Toxicol"},{"key":"4893_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuropharm.2011.06.024","volume":"61","author":"E Perdona'","year":"2011","unstructured":"Perdona' E, Costantini VJ, Tessari M, Martinelli P, Carignani C, Valerio E, Mok MH, Zonzini L, Visentini F, Gianotti M, Gordon L, Rocheville M, Corsi M, Capelli AM (2011) In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE). Neuropharmacology 61:957\u2013966","journal-title":"Neuropharmacology"},{"key":"4893_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/alcalc\/agx030","volume":"52","author":"M Reynaud","year":"2017","unstructured":"Reynaud M, Aubin HJ, Trinquet F, Zakine B, Dano C, Dematteis M, Trojak B, Paille F, Detilleux M (2017) A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients-the ALPADIR study. Alcohol Alcohol 52:439\u2013446","journal-title":"Alcohol Alcohol"},{"key":"4893_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0893-133X(96)00002-4","volume":"15","author":"DC Roberts","year":"1996","unstructured":"Roberts DC, Andrews MM, Vickers GJ (1996) Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15:417\u2013423","journal-title":"Neuropsychopharmacology"},{"key":"4893_CR31","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/sj.npp.1300734","volume":"30","author":"DA Slattery","year":"2005","unstructured":"Slattery DA, Markou A, Froestl W, Cryan JF (2005) The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30:2065\u20132072","journal-title":"Neuropsychopharmacology"},{"key":"4893_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1152\/physrev.00013.2008","volume":"89","author":"R Spanagel","year":"2009","unstructured":"Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 89:649\u2013705","journal-title":"Physiol Rev"},{"key":"4893_CR33","doi-asserted-by":"crossref","unstructured":"Spanagel R (2017) Animal models of addiction. Dialogues Clin Neurosci 19(2)","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel"},{"key":"4893_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/alcalc\/34.2.231","volume":"34","author":"R Spanagel","year":"1999","unstructured":"Spanagel R, H\u00f6lter SM (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol Alcohol 34:231\u2013243","journal-title":"Alcohol Alcohol"},{"key":"4893_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/adb.12109","volume":"18","author":"R Spanagel","year":"2013","unstructured":"Spanagel R, Durstewitz D, Hansson A, Heinz A, Kiefer F, K\u00f6hr G, Matth\u00e4us F, N\u00f6then MM, Noori HR, Obermayer K, Rietschel M, Schloss P, Scholz H, Schumann G, Smolka M, Sommer W, Vengeliene V, Walter H, Wurst W, Zimmermann US, Addiction GWAS Resource Group., Stringer S, Smits Y, Derks EM (2013) A systems medicine research approach for studying alcohol addiction. Addict Biol 18:883\u2013896","journal-title":"Addict Biol"},{"key":"4893_CR36","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00213-017-4576-y","volume":"234","author":"TT Takahashi","year":"2017","unstructured":"Takahashi TT, Vengeliene V, Spanagel R (2017) Melatonin reduces motivation for cocaine self-administration and prevents relapse-like behavior in rats. Psychopharmacology 234:1741\u20131748","journal-title":"Psychopharmacology"},{"key":"4893_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjp.2008.30","volume":"154","author":"V Vengeliene","year":"2008","unstructured":"Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299\u2013315","journal-title":"Br J Pharmacol"},{"key":"4893_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1369-1600.2009.00177.x","volume":"14","author":"V Vengeliene","year":"2009","unstructured":"Vengeliene V, Celerier E, Chaskiel L, Penzo F, Spanagel R (2009) Compulsive alcohol drinking in rodents. Addict Biol 14:384\u2013396","journal-title":"Addict Biol"},{"key":"4893_CR39","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.biopsych.2010.05.029","volume":"68","author":"V Vengeliene","year":"2010","unstructured":"Vengeliene V, Leonardi-Essmann F, Sommer WH, Marston HM, Spanagel R (2010) Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats. Biol Psychiatry 68:704\u2013711","journal-title":"Biol Psychiatry"},{"key":"4893_CR40","doi-asserted-by":"publisher","first-page":"E322","DOI":"10.1111\/j.1530-0277.2012.01874.x","volume":"37","author":"V Vengeliene","year":"2013","unstructured":"Vengeliene V, Noori HR, Spanagel R (2013) The use of a novel drinkometer system for assessing pharmacological treatment effects on ethanol consumption in rats. Alcohol Clin Exp Res 37:E322\u2013E328","journal-title":"Alcohol Clin Exp Res"},{"key":"4893_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.alcohol.2014.03.002","volume":"48","author":"V Vengeliene","year":"2014","unstructured":"Vengeliene V, Bilbao A, Spanagel R (2014) The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice. Alcohol 48:313\u2013320","journal-title":"Alcohol"},{"key":"4893_CR42","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/npp.2015.225","volume":"41","author":"V Vengeliene","year":"2016","unstructured":"Vengeliene V, Moeller A, Meinhardt MW, Beardsley PM, Sommer WH, Spanagel R, Bespalov A (2016) The Calpain inhibitor A-705253 attenuates alcohol-seeking and relapse with low side-effect profile. Neuropsychopharmacology 41:979\u2013988","journal-title":"Neuropsychopharmacology"},{"key":"4893_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1530-0277.2006.00259.x","volume":"31","author":"BM Walker","year":"2007","unstructured":"Walker BM, Koob GF (2007) The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res 31:11\u201318","journal-title":"Alcohol Clin Exp Res"},{"key":"4893_CR44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0022-3565(24)35044-X","volume":"290","author":"ZX Xi","year":"1999","unstructured":"Xi ZX, Stein EA (1999) Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther 290:1369\u20131374","journal-title":"J Pharmacol Exp Ther"},{"key":"4893_CR45","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1523\/JNEUROSCI.4977-13.2014","volume":"34","author":"KA Young","year":"2014","unstructured":"Young KA, Franklin TR, Roberts DC, Jagannathan K, Suh JJ, Wetherill RR, Wang Z, Kampman KM, O'Brien CP, Childress AR (2014) Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues. J Neurosci 34:5038\u20135043","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-4893-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:32:38Z","timestamp":1751560358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-4893-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4893"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-4893-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}